BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22305240)

  • 1. Microsatellite instability status does not predict total lymph node or negative lymph node retrieval in stage III colon cancer.
    MacQuarrie E; Arnason T; Gruchy J; Yan S; Drucker A; Huang WY
    Hum Pathol; 2012 Aug; 43(8):1258-64. PubMed ID: 22305240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lymph node evaluation and long-term survival in Stage II and Stage III colon cancer: a national study.
    Vather R; Sammour T; Kahokehr A; Connolly AB; Hill AG
    Ann Surg Oncol; 2009 Mar; 16(3):585-93. PubMed ID: 19116751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
    Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
    J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical impact of microsatellite instability in colon cancer following adjuvant FOLFOX therapy.
    Kim ST; Lee J; Park SH; Park JO; Lim HY; Kang WK; Kim JY; Kim YH; Chang DK; Rhee PL; Kim DS; Yun H; Cho YB; Kim HC; Yun SH; Lee WY; Chun HK; Park YS
    Cancer Chemother Pharmacol; 2010 Sep; 66(4):659-67. PubMed ID: 20033812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relation between lymph node status and survival in Stage I-III colon cancer: results from a prospective nationwide cohort study.
    Lykke J; Roikjaer O; Jess P;
    Colorectal Dis; 2013 May; 15(5):559-65. PubMed ID: 23061638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between a high number of isolated lymph nodes in T1 to T4 N0M0 colorectal cancer and the microsatellite instability phenotype.
    Eveno C; Nemeth J; Soliman H; Praz F; de The H; Valleur P; Talbot IC; Pocard M
    Arch Surg; 2010 Jan; 145(1):12-7. PubMed ID: 20083749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph node yield after colectomy for cancer: is absence of mismatch repair a factor?
    Samdani T; Schultheis M; Stadler Z; Shia J; Fancher T; Misholy J; Weiser MR; Nash GM
    Dis Colon Rectum; 2015 Mar; 58(3):288-93. PubMed ID: 25664706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ratio as prognosis factor for colon cancer treated by colorectal surgeons.
    Vaccaro CA; Im V; Rossi GL; Quintana GO; Benati ML; Perez de Arenaza D; Bonadeo FA
    Dis Colon Rectum; 2009 Jul; 52(7):1244-50. PubMed ID: 19571700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymph node counts, rates of positive lymph nodes, and patient survival for colon cancer surgery in Ontario, Canada: a population-based study.
    Bui L; Rempel E; Reeson D; Simunovic M
    J Surg Oncol; 2006 May; 93(6):439-45. PubMed ID: 16615148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mismatch repair system and p53 expression in patients with T1 and T2 colorectal cancer: predictive role of lymph node metastasis and survival.
    Huh JW; Kim HC; Kim SH; Park YA; Cho YB; Yun SH; Lee WY; Chun HK
    J Surg Oncol; 2014 Jun; 109(8):848-52. PubMed ID: 24623275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of microsatellite instability in T1 colorectal cancer.
    Kang J; Lee HW; Kim IK; Kim NK; Sohn SK; Lee KY
    Yonsei Med J; 2015 Jan; 56(1):175-81. PubMed ID: 25510762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of lymph node retrieval and pathological ultra-staging on the prognosis of stage II colon cancer.
    Law CH; Wright FC; Rapanos T; Alzahrani M; Hanna SS; Khalifa M; Smith AJ
    J Surg Oncol; 2003 Nov; 84(3):120-6. PubMed ID: 14598354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
    Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
    Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Young age influences treatment but not outcome of colon cancer.
    Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio as determined by the 7th edition of the American Joint Committee on Cancer staging system predicts survival in stage III colon cancer.
    Hong KD; Lee SI; Moon HY
    J Surg Oncol; 2011 Apr; 103(5):406-10. PubMed ID: 21400524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodal stage of stage III colon cancer: the impact of metastatic lymph node ratio.
    Park IJ; Choi GS; Jun SH
    J Surg Oncol; 2009 Sep; 100(3):240-3. PubMed ID: 19330780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability is associated with reduced disease specific survival in stage III colon cancer.
    Mohan HM; Ryan E; Balasubramanian I; Kennelly R; Geraghty R; Sclafani F; Fennelly D; McDermott R; Ryan EJ; O'Donoghue D; Hyland JM; Martin ST; O'Connell PR; Gibbons D; Winter D; Sheahan K
    Eur J Surg Oncol; 2016 Nov; 42(11):1680-1686. PubMed ID: 27370895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ex vivo sentinel lymph node mapping in colon cancer: improving the accuracy of pathologic staging?
    Smith J; Hwang H; Wiseman KW; Filipenko D; Phang PT
    Am J Surg; 2006 May; 191(5):665-8. PubMed ID: 16647356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic significance of extramural deposits and extracapsular lymph node invasion in colon cancer.
    Al Sahaf O; Myers E; Jawad M; Browne TJ; Winter DC; Redmond HP
    Dis Colon Rectum; 2011 Aug; 54(8):982-8. PubMed ID: 21730787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing the number of lymph nodes examined after colectomy does not improve colon cancer staging.
    Budde CN; Tsikitis VL; Deveney KE; Diggs BS; Lu KC; Herzig DO
    J Am Coll Surg; 2014 May; 218(5):1004-11. PubMed ID: 24661856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.